0001140361-18-013108.txt : 20180312
0001140361-18-013108.hdr.sgml : 20180312
20180312182225
ACCESSION NUMBER: 0001140361-18-013108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180308
FILED AS OF DATE: 20180312
DATE AS OF CHANGE: 20180312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liang Samuel M.
CENTRAL INDEX KEY: 0001618037
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 18684734
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2018-03-08
0
0000722723
HANGER, INC.
HGR
0001618037
Liang Samuel M.
10910 DOMAIN DRIVE, SUITE 300
AUSTIN
TX
78758
0
1
0
0
Executive Vice President*
Common Stock
2018-03-08
4
F
0
1370
15.70
D
96588
D
Common Stock
2018-03-09
4
A
0
20701
0
A
117289
D
Stock Options (right to buy)
12.77
2027-05-19
Common Stock
72231
72231
D
Performance Share Units
2020-05-19
Common Stock
28892
28892
D
Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued.
Represents a grant of time-based restricted stock under the Company's 2016 Omnibus Incentive Plan ("Plan"), which vests to the extent of 25% annually beginning on March 9, 2019 and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 20,701 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2018.
Includes (i) unvested restricted shares totaling 20,701 shares of stock from an initial grant of 20,701 shares of restricted stock that begins to vest on March 9, 2019; (ii) unvested restricted shares and fully vested shares totaling 20,666 shares of stock from an initial grant of 20,666 shares of restricted stock, half of which vested on January 25, 2018 and the remainder of which will vest on March 7, 2018 and 2019; (iii) unvested restricted shares and fully vested shares totaling 21,130 shares of stock from an initial grant of 22,500 shares of restricted stock that begins to vest on March 8, 2018; (iv) unvested restricted shares and fully vested shares totaling 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 22,500 shares of stock from an initial grant of 22,500 shares of restricted stock that begins to vest on March 7, 2017; (vi) unvested restricted shares and fully vested shares totaling 13,777 shares of stock from an initial grant of 13,777 shares of restricted stock made on March 6, 2015 and (vii) unvested restricted shares and fully vested shares totaling 13,515 shares of stock from an initial grant of 14,745 shares of restricted stock made on May 19, 2014. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.
* The reporting person is Executive Vice President of Hanger, Inc. and President and Chief Operating Officer of Hanger Prosthetics & Orthotics, Inc.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Samuel M. Liang
2018-03-12